Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

New Loan Facility

10 Dec 2009 07:00

RNS Number : 8848D
China Real Estate Opportunities PLC
10 December 2009
Β 

ο»Ώ

10Β DecemberΒ 2009

China Real Estate OpportunitiesΒ plcΒ obtains refinancing for Shanghai'sΒ TreasuryΒ Building

China Real Estate Opportunities plc ("CREO" or the "Company"),Β is pleased to announceΒ theΒ completion of a loan facilityΒ for a multi-currency threeΒ year loan equivalent toΒ Β£27.72Β million (US$37.8Β million offshore loanΒ plusΒ RMB50 million onshore),Β based on current exchange rates,Β withΒ CITICΒ KaΒ WahΒ Bank inΒ Hong Kong.Β This new loan facility, the terms of which were previously announced in August 2009,Β will replaceΒ the existing €18.8 million and RMB97 million loanΒ (equivalent toΒ Β£25.80 million)Β CREO has in regard to the Treasury BuildingΒ inΒ ShanghaiΒ with Credit Suisse which was due to expire in March 2010.Β 

Under the finalΒ terms,Β CREOΒ will benefit fromΒ significantlyΒ lowerΒ interest costs asΒ the newΒ loan facilityΒ reflectsΒ an interest rate of 3.50% overΒ the designated base rateΒ for the foreign currency component andΒ a total interest rate ofΒ 6.37% for the RMB portion. TheΒ blendedΒ rateΒ currently equates to approximatelyΒ 4.20% per annumΒ compared toΒ theΒ average cost of funds ofΒ more thanΒ 6.75%Β forΒ the current loan.

Ray Horney,Β CREOΒ Chairman commented,Β "We completed the Treasury Building refinancing onΒ extremely competitive termsΒ due to interest from a number of local and regional banks in thisΒ assetΒ and are naturally very pleased with the outcome whichΒ clearlyΒ shows that Asian banks are still open for business and that quality, well-managed assets will always be able to sourceΒ competitive financing.".Β 

Contact:

China Real Estate Opportunities plc

Ray Horney, Chairman

Tel: + 44 (0) 1273 775 225Β 

Sarah Moriarty, Investor Relations

Tel: + 353 1 618 9455

Matrix Corporate Capital LLP

Paul Fincham

Tel: + 44 (0) 20 3206 7000

Davy

Des Carville

Tel: + 353 1 679 6363

Citigate Dewe Rogerson Limited

Tom BaldockΒ (London)

Tel: + 44 (0) 20 7638 9571

Charlotte BilneyΒ (Hong Kong)

Tel: +852 2533 4620

MurrayΒ ConsultantsΒ 

Ed Micheau

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCFKLLBKLBFFBV
Date   Source Headline
28th Jun 202212:33 pmRNSResult of AGM
28th Jun 20227:00 amRNSAGM Statement
27th May 20227:00 amRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSPosting of 2021 Annual Report and Accounts
23rd May 20227:01 amRNSFinal Results
23rd May 20227:00 amRNSCollaboration agreement with Intuitive
18th May 20223:22 pmRNSHolding(s) in Company
17th May 20227:00 amRNSNotice of Results
28th Apr 20227:00 amRNSTrading update and notice of results
20th Apr 20227:00 amRNSOpening of Singapore regional hub
5th Apr 20227:00 amRNSCTO wins Technology Innovator of the Year Award
16th Mar 20227:00 amRNSAlbyn Medical earn out update
28th Feb 20227:00 amRNSTotal Voting Rights
7th Feb 20227:00 amRNSPresentation at Growth and Innovation Forum 2022
4th Feb 20227:00 amRNSAward of Shares under Share Incentive Plan
3rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20224:35 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSTrading update
24th Jan 20227:00 amRNSLicensing & Partnership update
31st Dec 20217:00 amRNSTotal Voting Rights
23rd Dec 20217:00 amRNSExercise of Options
30th Nov 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSExercise of Options
12th Nov 20217:00 amRNSAcquisition of Aber Electronics Limited
11th Nov 20217:00 amRNSAppointment of Joint Broker
30th Sep 202112:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSHalf-year Report
9th Sep 202111:23 amRNSDirector/PDMR Shareholding
8th Sep 20213:59 pmRNSHolding(s) in Company
16th Aug 20213:34 pmRNSOpen Offer Launch, Posting of Circular & GM Notice
13th Aug 20214:45 pmRNSResult of Placing
12th Aug 20215:37 pmRNSProposed Placing & Open Offer, Launch of ABB
30th Jul 20215:00 pmRNSTotal Voting Rights
20th Jul 20213:42 pmRNSShare Awards, Director Dealings & Issue of Equity
16th Jul 20217:00 amRNSOpening of United States East Coast Headquarters
1st Jul 20218:00 amRNSIssue of Equity
30th Jun 202110:30 amRNSResult of AGM
16th Jun 20217:00 amRNSMicroBlate Fine’s first in-human use update
14th Jun 20217:00 amRNSAcquisition of freehold site for £4.25m
4th Jun 20217:01 amRNSNotice of AGM
4th Jun 20217:00 amRNSFinal Results
26th May 20217:00 amRNSFurther health economics data validates technology
19th May 20217:00 amRNSTrading Update
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSExercise of Options
19th Feb 202111:31 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSTrading update
7th Jan 20217:00 amRNSUS FDA clearance for MicroBlate™ Flex device
9th Dec 202011:06 amRNSSecond Price Monitoring Extn
9th Dec 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.